Exosome Diagnostics Market to Surge: Projected Growth from USD 59M to USD 2,347M by 2029 | MarketsandMarkets™ [Yahoo! Finance]
Bio-Techne Corp (TECH)
Last bio-techne corp earnings: 4/30 06:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.bio-techne.com
Company Research
Source: Yahoo! Finance
from USD 59 million in 2024 to USD 2,347 million by 2029, reflecting a compound annual growth rate (CAGR) of 108.9%. However, the launch of exosome-based therapeutics is expected to commence from 2029 onward. Overall, the market, valued at USD 59 million in 2024, is projected to reach USD 6,848 million by 2032, growing at a CAGR of 81.2% from 2024 to 2032. Key drivers of this growth include increasing initiatives for product commercialization, particularly in the exosome therapeutics segment, and the rising adoption of exosome biomarkers for personalized medicine applications. However, the market faces challenges such as technical complexities in exosome isolation and inadequate protocols for development and production. Major players in this evolving market include Bio-Techne (US), NanoFCM Inc. (UK), System Biosciences, LLC. (US), and others actively advancing exosome-based technologies across diagnostics and therapeutics. Download PDF Brochure: https://www.marketsandmarkets.com/pdf
Show less
Read more
Impact Snapshot
Event Time:
TECH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TECH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TECH alerts
High impacting Bio-Techne Corp news events
Weekly update
A roundup of the hottest topics
TECH
News
- Declining Stock and Decent Financials: Is The Market Wrong About Bio-Techne Corporation (NASDAQ:TECH)? [Yahoo! Finance]Yahoo! Finance
- Exosome Diagnostics and Therapeutics Market Surges, Anticipated to Hit USD 6,848 Million by 2032 | MarketsandMarkets™ [Yahoo! Finance]Yahoo! Finance
- Exosomes Development and Manufacturing Market Worth USD 62.8 Billion to 2031- Best Report by InsightAce Analytic Pvt. Ltd. [Yahoo! Finance]Yahoo! Finance
- BioPharmaSpec Announces Major Investments in Mass Spectrometry and Related Instrumentation [Yahoo! Finance]Yahoo! Finance
- BioPharmaSpec Announces Major Investments in Mass Spectrometry and Related Instrumentation [Financial Post (Toronto, Ontario, Canada)]Financial Post
TECH
Earnings
- 5/1/24 - Beat
TECH
Sec Filings
- 5/31/24 - Form SD
- 5/16/24 - Form 4
- 5/14/24 - Form 144
- TECH's page on the SEC website